Table 1.
Summary of Demographic and Clinical Variables in Respondents
| Overall | Males | Females | Missing | |
|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | |
| Gender | ||||
| male | 150 (37) | ~ | ~ | ~ |
| female | 232 (57.3) | ~ | ~ | ~ |
| missing | 23 (5.7) | ~ | ~ | ~ |
| Age | ||||
| ≤50 | 214 (52.8) | 78 (53.8%) | 135 (60%) | 1 |
| >50 | 157 (38.8) | 67(46.2%) | 90 (40%) | 0 |
| missing | 34 (8.4) | |||
| Race | ||||
| White | 371 (91.6) | 145 (96.7) | 223 (96.5) | 3 |
| Black or African American | 3 (0.7) | 1 (0.7) | 2 (0.9) | |
| Asian | 4 (1.0) | 3 (2) | 1 (0.4) | |
| Other | 6 (1.5) | 1 (0.7) | 5 (2.2) | |
| Missing | 21 (5.2) | |||
| Cancer history | ||||
| Any Cancer | 282 (69.6) | 97(70.3) | 169(75.8) | 16 |
| Prostate Cancer | 144 (35.6) | 55(43.7) | 82(42.7) | 7 |
| Breast Cancer | 59 (14.6) | 21(18.1) | 36(21.4) | 2 |
| Pancreatic Cancer | 45 (11.1) | 10(9.9) | 34(20.2) | 1 |
| Melanoma | 55 (13.6) | 19(18.3) | 33(21.4) | 3 |
| BRCA status | ||||
| BRCA1 in family | 200 (49.4) | 74(49.3) | 109(47.0) | 17 |
| BRCA2 in family | 205 (50.6) | 76(50.7) | 123(53.0) | 6 |
| tested/positive | 322 (79.5) | 97(64.7) | 209(90.5) | 16 |
| tested/negative | 15 (3.7) | 4(2.7) | 11(4.8) | 0 |
| Not tested | 64 (15.8) | 49(32.7) | 11(4.8) | 4 |